AstraZeneca launches K+ Connect to advance hyperkalemia management in heart failure, chronic kidney disease across India Read more
CKD-hyperparathyroidism, hyperphosphatemia, hyperkalemia market to grow at 6.9% CAGR by 2030: GlobalData Read more